litlas
ログインアカウント作成

Atul Deodhar

1994–2025 年に発表

159
論文数
18,232
被引用数
76
h 指数
145
i10 指数

被引用数

Atul Deodhar の年別被引用数1986 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 3 件1997 年: 被引用 1 件1999 年: 被引用 3 件2000 年: 被引用 8 件2001 年: 被引用 7 件2002 年: 被引用 4 件2003 年: 被引用 5 件2004 年: 被引用 6 件2005 年: 被引用 9 件2006 年: 被引用 4 件2007 年: 被引用 2 件2008 年: 被引用 7 件2009 年: 被引用 23 件2010 年: 被引用 24 件2011 年: 被引用 48 件2012 年: 被引用 34 件2013 年: 被引用 43 件2014 年: 被引用 53 件2015 年: 被引用 85 件2016 年: 被引用 104 件2017 年: 被引用 133 件2018 年: 被引用 168 件2019 年: 被引用 637 件2020 年: 被引用 956 件2021 年: 被引用 939 件2022 年: 被引用 759 件2023 年: 被引用 567 件2024 年: 被引用 938 件2025 年: 被引用 398 件2026 年: 被引用 5 件1987〜1994 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,208 件、この内訳の 17%イギリス: 引用元論文 643 件、この内訳の 9.1%ドイツ: 引用元論文 518 件、この内訳の 7.3%カナダ: 引用元論文 413 件、この内訳の 5.8%中国: 引用元論文 395 件、この内訳の 5.6%フランス: 引用元論文 339 件、この内訳の 4.8%イタリア: 引用元論文 337 件、この内訳の 4.8%オランダ: 引用元論文 335 件、この内訳の 4.7%スペイン: 引用元論文 255 件、この内訳の 3.6%スイス: 引用元論文 232 件、この内訳の 3.3%ベルギー: 引用元論文 207 件、この内訳の 2.9%日本: 引用元論文 178 件、この内訳の 2.5%
0%17%その他 28.6%

機関

分野

  • Medicine74.9%
  • Immunology and Microbiology17.3%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Neuroscience0.4%
  • Nursing0.3%
  • Health Professions0.3%
  • その他1.6%

トピック

  • Spondyloarthritis Studies and Treatments18.3%
  • Rheumatoid Arthritis Research and Therapies14.7%
  • Psoriasis: Treatment and Pathogenesis12.2%
  • Autoimmune and Inflammatory Disorders Research5.4%
  • Spine and Intervertebral Disc Pathology2.7%
  • Dermatology and Skin Diseases2.5%
  • その他44.2%

共著者

全論文

検索で開く
  1. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

    著者: Gerd R Burmester, Stanley Cohen, Kevin Winthrop, Peter Nash, Alan D. Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P. Lacerda, Hannah Palac, Tim Shaw, Philip J. Mease, Emma Guttman‐Yassky - RMD Open 2023 被引用: 210

  2. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

    著者: Michael M. Ward, Atul Deodhar, Lianne S. Gensler, Maureen Dubreuil, David Tak Yan Yu, Muhammad Asim Khan, Nigil Haroon, David Borenstein, Runsheng Wang, Ann Biehl, Meika A. Fang, Grant H. Louie, Vikas Majithia, Bernard Ng, Rosemary Bigham, Michael Pianin, Amit Shah, Nancy Sullivan, Marat Turgunbaev, Jeff Oristaglio, Amy S. Turner, Walter P. Maksymowych, Liron Caplan - Arthritis & Rheumatology 2019 被引用: 692

  3. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

    著者: Dominique Baeten, Joachim Sieper, Jürgen Braun, Xenofon Baraliakos, Maxime Dougados, Paul Emery, Atul Deodhar, Brian Porter, Ruvie Martin, Mats Andersson, Shephard Mpofu, Hanno B. Richards - New England Journal of Medicine 2015 被引用: 1,003

  4. Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis

    著者: Philip J. Mease, Atul Deodhar, Désirée van der Heijde, Frank Behrens, Alan Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee - Annals of the Rheumatic Diseases 2022 被引用: 204

  5. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

    著者: Désirée van der Heijde, In-Ho Song, Aileen L. Pangan, Atul Deodhar, Filip Van den Bosch, Walter P. Maksymowych, Tae‐Hwan Kim, Mitsumasa Kishimoto, Andrea Everding, Yunxia Sui, Xin Wang, Alvina D. Chu, Joachim Sieper - The Lancet 2019 被引用: 346

  6. Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

    著者: Atul Deodhar, Philip Helliwell, Wolf‐­Henning Boehncke, Alexa P. Kollmeier, Elizabeth C. Hsia, Ramanand A. Subramanian, Xie L. Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Christopher T Ritchlin - The Lancet 2020 被引用: 322

  7. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

    著者: Atul Deodhar, Paula Śliwińska-Stańczyk, Huji Xu, Xenofon Baraliakos, Lianne S. Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S. Kanik, Désirée van der Heijde - Annals of the Rheumatic Diseases 2021 被引用: 248

  8. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Atul Deodhar, Filip Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée van der Heijde, Tae‐Hwan Kim, Mitsumasa Kishimoto, Ricardo Blanco, Yuanyuan Duan, Yihan Li, Aileen L. Pangan, Peter Wung, In‐Ho Song - The Lancet 2022 被引用: 135

  9. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

    著者: Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette C. Siaton, Benjamin J. Smith, Abby S. Van Voorhees, A. Helena Jonsson, Amit Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice B. Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, José U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner, James Reston - Arthritis & Rheumatology 2018 被引用: 481

  10. Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

    著者: Désirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul Deodhar, Robert D. Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L. Pangan, Peter Wung, In‐Ho Song - Annals of the Rheumatic Diseases 2022 被引用: 124

  11. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group

    著者: Walter P. Maksymowych, R. Lambert, Mikkel Østergaard, Susanne Juhl Pedersen, Pedro Machado, Ulrich Weber, Alexander N. Bennett, Juergen Braun, Rubén Burgos‐Vargas, Manouk de Hooge, Atul Deodhar, Iris Eshed, Anne Grethe Jurik, Kay‐Geert Hermann, Robert Landewé, Helena Marzo‐Ortega, Victoria Navarro‐Compán, Denis Poddubnyy, M. Reijnierse, Martín Rudwaleit, Joachim Sieper, Filip Van den Bosch, Désirée van der Heijde, Irene E. van der Horst‐Bruinsma, Stephanie Wichuk, Xenofon Baraliakos - Annals of the Rheumatic Diseases 2019 被引用: 304

  12. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

    著者: Désirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, Matthew Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, A.M. Ellis, C. Fleurinck, Karl Gaffney, Lianne S. Gensler, Nigil Haroon, Marina Magrey, Walter P. Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martín Rudwaleit, Julie Shepherd‐Smith, Tetsuya Tomita, Filip Van den Bosch, T. Vaux, Huji Xu - Annals of the Rheumatic Diseases 2023 被引用: 106

  13. Treatment of axial spondyloarthritis: an update

    著者: Abhijeet Danve, Atul Deodhar - Nature Reviews Rheumatology 2022 被引用: 154

  14. Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data

    著者: Atul Deodhar, P. J. Mease, Iain B. McInnes, Xenofon Baraliakos, Kristian Reich, Andrew Blauvelt, C. Leonardi, Brian Porter, Ayan Das Gupta, A. Widmer, Luminita Pricop, T. Fox - Arthritis Research & Therapy 2019 被引用: 293

  15. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    著者: Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd‐Ruediger Burmester, David Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark C. Genovese, Khalid Ahmed, Jeffrey Alper, N Barkham, Ralph E. Bennett, Francisco J. Blanco, Ricardo Blanco Alonso, Howard Blumstein, Michael S. Brooks, Gerd‐Rüdiger Burmester, Patricia Cagnoli, Paul H. Caldron, Alain Cantagrel, Der‐Yuan Chen, Melvin Churchill, Christine E. Codding, Benard Combe, Peter M.G. Deane, José Del Giudice, Atul Deodhar, Rajat K. Dhar, Eva Dokoupilová, Rita M. Egan, Andrea Everding, E. Galíndez, Mark C. Genovese, David H. Goddard, Alice B. Gottlieb, Philippe Goupille, Robert Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu‐Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Klein, Mariusz Korkosz, Roshan Kotha, Joel M. Kremer, C Lue, José Luís Marenco de la Fuente, Helena Marzo‐Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama Nandagudi, Peter Nash, Antonio Fernández‐Nebro, C. Michael Neuwelt, Ana‐Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria Rell‐Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen‐Fang Tsai, Anthony Turkiewicz, L. Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielińska - The Lancet 2017 被引用: 405

  16. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

    著者: Désirée van der Heijde, Atul Deodhar, James Cheng‐Chung Wei, Edit Drescher, Dona Fleishaker, Thijs Hendrikx, David Li, Sujatha Menon, Keith S. Kanik - Annals of the Rheumatic Diseases 2017 被引用: 369

  17. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

    著者: Atul Deodhar, Lianne S. Gensler, Joachim Sieper, Michael B. Clark, César A. Calderón, Yuhua Wang, Yiying Zhou, Jocelyn H. Leu, Kim Campbell, Kristen Sweet, Diane D. Harrison, Elizabeth C. Hsia, Désirée van der Heijde - Arthritis & Rheumatology 2018 被引用: 323

  18. Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

    著者: Alice B. Gottlieb, Atul Deodhar, Iain B. McInnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Kwaku Marfo, Hanno B. Richards, Luminita Pricop, Abhijit Shete, Vivek Trivedi, Deborah Keefe, C. Papavassilis, Piotr Jagiello, P. Papanastasiou, Philip J. Mease, Mark Lebwohl - Acta Dermato Venereologica 2022 被引用: 94

  19. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    著者: Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados, Philip J. Mease, Atul Deodhar, Walter P. Maksymowych, Filip Van den Bosch, Joachim Sieper, Tetsuya Tomita, Robert Landewé, Fangyi Zhao, Eswar Krishnan, David H. Adams, Beth A. Pangallo, Hilde Carlier, Melvin Churchill, Kathleen P. Flint, Geoffrey Gladstein, Maria Greenwald, Mary P. Howell, Akgun Ince, Jeffrey Kaine, Daksha Mehta, Eric Peters, Roel Querubin, John D. Reveille, Richard Roseff, Roger J. Diegel, Christine Thai, Louis Bessette, Frédéric Morin, Proton Rahman, Aaron Alejandro Barrera Rodriguez, Fidencio Cons-Molina, Sergio Duran Barragan, Cassandra M. Skinner, César Pacheco‐Tena, César Ramos-Remus, Juan Cruz Rizo Rodriguez, Seung-Jae Hong, Yeon-Ah Lee, Ji Hyeon Ju, Seong Wook Kang, Tae‐Hwan Kim, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min‐Chan Park, Kichul Shin, Sang‐Hoon Lee, Hung-An Chen, Ying‐Chou Chen, Song‐Chou Hsieh, Joung‐Liang Lan, Zdeněk Dvořák, Radka Moravcová, Martina Malcova, Yoshinori Taniguchi, Mitsumasa Kishimoto, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Yoshinobu Koyama, Kazuhiro Hatta, Tatsuya Atsumi, Midori Goto, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Denis Poddubnyy, Andrea Rubbert‐Roth, Malgorzata Szymańska, Tomasz Blicharski, Anna Dudek, Artur Racewicz, Rafał Wojciechowski, Marleen van de Sande, E. N. Griep, Mike Nurmohamed, Galina Matsievskaya, Е. Шмидт, Marina Stanislav, S. S. Yakushin, О. Б. Ершова, А. П. Ребров, Tibor Balázs, Regina Cseuz, Edit Drescher, Gyula Poór - The Lancet 2018 被引用: 359

  20. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

    著者: Désirée van der Heijde, Xenofon Baraliakos, Lianne S. Gensler, Walter P. Maksymowych, Vira Tseluyko, Oleg Nadashkevich, Walid Abi‐Saab, Chantal Tasset, Luc Meuleners, R. Besuyen, Thijs Hendrikx, Neelufar Mozaffarian, Ke Liu, Joy M. Greer, Atul Deodhar, Robert Landewé - The Lancet 2018 被引用: 256

  21. Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies

    著者: Philip J. Mease, Philip Helliwell, Dafna D. Gladman, Denis Poddubnyy, Xenofon Baraliakos, Soumya D. Chakravarty, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Kristen Sweet, M. Shawi, Chetan S. Karyekar, Atul Deodhar, Désirée van der Heijde - The Lancet Rheumatology 2021 被引用: 102

  22. Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis

    著者: Bruce Strober, Laura C. Coates, Mark Lebwohl, Atul Deodhar, Evan Leibowitz, Katelyn Rowland, Alexa P. Kollmeier, Megan Miller, Yanli Wang, Shu Li, Soumya D. Chakravarty, Daphne Chan, M. Shawi, Ya‐Wen Yang, Diamant Thaҫi, Proton Rahman - Drug Safety 2023 被引用: 55

  23. Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

    著者: Atul Deodhar, Denis Poddubnyy, César Pacheco‐Tena, Carlo Salvarani, Éric Lespessailles, Proton Rahman, Pentti A. Järvinen, Juan Sánchez‐Bursón, Karl Gaffney, Eun Bong Lee, Eswar Krishnan, Silvia Santisteban, Xiaoqi Li, Fangyi Zhao, Hilde Carlier, John D. Reveille, the COAST‐W Study Group - Arthritis & Rheumatology 2018 被引用: 233

  24. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

    著者: Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler, Tae‐Hwan Kim, Walter P. Maksymowych, Mikkel Østergaard, Denis Poddubnyy, Helena Marzo‐Ortega, Louis Bessette, Tetsuya Tomita, Ann N. Leung, Maja Hojnik, Gaia Gallo, Xiaoqi Li, David H. Adams, Hilde Carlier, Joachim Sieper, Frédéric Morin, Proton Rahman, Federico Ariel, Alberto Berman, Judith Carrio, Eleonora Lucero, José Maldonado Cocco, Rodolfo Pardo Hidalgo, Jorge Antonio Aldrete Velasco, Diego Oscar Viola, Johannes Grisar, Heinrich Resch, Clemens Scheinecker, Ana Claudia Melazzi, Luis Roimicher, Antônio Scafuto Scotton, Aaron Alejandro Barrera Rodriguez, Francisco Fidencio Cons Molina, Sergio Duran Barragan, Cassandra M. Skinner, César Pacheco‐Tena, Cesar Ricardo Ramos Remus, Juan Cruz Rizo Rodriguez, Seung‐Jae Hong, Seong Wook Kang, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min‐Chan Park, Sang‐Hoon Lee, Eva Dokoupilová, Zdeněk Dvořák, Martina Malcova, Karel Pvelka, Kari K. Eklund, Pentti A. Järvinen, Anna Karjalainen, Leena Paimela, Yoshinori Taniguchi, Tokutaro Tsuda, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Kazuhiro Hatta, Tatsuya Atsumi, Midori Goto, Shigeru Honjo, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Sylke Wagner, Jürgen Braun, Tomasz Blicharshi, Anna Dudek, Pawel Hrycai, Rafal Plebanski, Janina Drabiszcak-Piatkowska, Jan Brzezicki, Marek Krogulec, Daniela Opriș-Belinski, Ana Maria Ramazan, Luminita Tronaru, Marleen G. van de Sande, Galina Matsievskaya, E. A. Schmidt, Marina Stanislav, S. S. Yakushin, О. Б. Ершова, Andrey Rebroy, Melvin Churchill, Kathleen P. Flint, Maria Greenwald, Mary P. Howell, Jeffrey Kaine, Alan Kivitz, Steven J. Klein, Eric C. Mueller, Eric Peters, Roel Querubin, Michael E. Sayers, Craig D. Scoville ほか 17 名 - The Lancet 2019 被引用: 214